Австралия - английский - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - tadalafil -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 20 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; lactose monohydrate; microcrystalline cellulose; macrogol 8000; croscarmellose sodium; iron oxide yellow; titanium dioxide; iron oxide red; poloxamer; hyprolose; hypromellose; magnesium stearate - indicated in adults for the treatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity. efficacy has been shown in idiopathic pah (ipah) and in pah related to collagen vascular disease.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 20 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hyprolose; lactose monohydrate; magnesium stearate; poloxamer; macrogol 8000; sodium lauryl sulfate; microcrystalline cellulose; titanium dioxide; iron oxide yellow; hypromellose - treatment of erectile dysfunction in adult males. this medicine is not indicated for use by women.

Канада - английский - Health Canada

apotex inc - tadalafil - tablet - 2.5mg - tadalafil 2.5mg - phosphodiesterase type 5 inhibitors

Канада - английский - Health Canada

apotex inc - tadalafil - tablet - 5mg - tadalafil 5mg - phosphodiesterase type 5 inhibitors

Канада - английский - Health Canada

apotex inc - tadalafil - tablet - 10mg - tadalafil 10mg - phosphodiesterase type 5 inhibitors

Соединенные Штаты - английский - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology ( 12.2)] . tadalafil tablet

Соединенные Штаты - английский - NLM (National Library of Medicine)

medsource pharmaceuticals - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology ( 12.2)] . tadalafil tablet

Саудовская Аравия - английский - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

apotex inc. (signet site), canada - tadalafil - tablet - 20 mg

Соединенные Штаты - английский - NLM (National Library of Medicine)

proficient rx lp - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil or adcirca®